Skip to main content
SpringerLink
Log in

Radiation Therapy in Basal Cell Carcinoma

  • Living reference work entry
  • First Online:
Radiation Oncology

  • 247 Accesses

Abstract

Surgery is the standard treatment of basal cell carcinoma and produces cure rates of 90–98%. Radiotherapy is an alternative in patients with contraindications to surgery (e.g., related to age or comorbidities) and in locally advanced basal cell carcinomas. Radiotherapy is delivered via electron or orthovoltage techniques and achieves cure rates of 83–95%. The choice of radiotherapy technique must consider the expected extent of the lesion and the characteristics of the chosen beam energy, especially surface and depth dose distribution. Typical dose regimens for electron radiotherapy are normofractionated or moderately hypofractionated while extremely hypofractionated concepts are available for the most elderly and frail patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abramson AK, Krasny MJ, Goldman GD. Tangential shave removal of basal cell carcinoma. Dermatol Surg. 2013;39(3Pt1):387–92.

    Article  CAS  Google Scholar 

  • Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, Guillaume JC, Chalon R, Petit JY, Sancho-Garnier H, Prade M, Bouzy J, Chassagne D. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76(1):100–6.

    Article  CAS  Google Scholar 

  • German Centre for Cancer Registry Data. In: Robert Koch Institute, the Association of Population-based Cancer Registries in Germany, editors. Cancer in Germany 2011/2012. 10th ed. Berlin: Robert Koch Institute; 2016.

    Google Scholar 

  • Chahal HS, Rieger KE, Sarin KY. Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. J Am Acad Dermatol. 2017;76(2):353–4.

    Article  Google Scholar 

  • Cho M, Gordon L, Rembielak A, Woo TC. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol. 2014;171(5):968–73.

    Article  CAS  Google Scholar 

  • Gunaratne DA, Veness MJ. Efficacy of hypofractionated radiotherapy in patients with non-melanoma skin cancer: results of a systematic review. J Med Imaging Radiat Oncol. 2018; https://doi.org/10.1111/1754-9485.12718. Epub ahead of print.

    Article  Google Scholar 

  • Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986;37(1):33–4.

    Article  CAS  Google Scholar 

  • Huynh NT, Veness MJ. Basal cell carcinoma of the lip treated with radiotherapy. Australas J Dermatol. 2002;43(1):15–9.

    Article  Google Scholar 

  • Khan L, Choo R, Breen D, Assaad D, Fialkov J, Antonyshyn O, McKenzie D, Woo T, Zhang L, Barnes E. Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiother Oncol. 2012;104(2):263–6.

    Article  Google Scholar 

  • Kossard S, Epstein EM, Cerio R, Yu LL, Weedon D. In: LeBoit PE, Burg G, Weedon D, Sarasin A, editors. WHO classification of tumors, Pathology and genetics of skin tumors. 1st ed. Lyon: IARC-Press; 2006.

    Google Scholar 

  • Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma. Br J Ophthalmol. 2013;97(6):730–4.

    Article  Google Scholar 

  • Kricker A, Weber M, Sitas F, Banks E, Rahman B, Goumas C, Kabir A, Hodgkinson VS, van Kemenade CH, Waterboer T, Armstrong BK. Early life UV and risk of basal and squamous cell carcinoma in New South Wales, Australia. Photochem Photobiol. 2017;93(6):1483–91.

    Article  CAS  Google Scholar 

  • NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer. Version I.2018 – September 18, 2017.

    Google Scholar 

  • Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt MH. Radiotherapy of basal cell carcinoma of the face and head: importance of low dose per fraction on long-term outcome. J Dtsch Dermatol Ges. 2006;4(2):124–30.

    Article  Google Scholar 

  • Ostheimer C, Hübsch P, Janich M, Gerlach R, Vordermark D. Dosimetric comparison of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in total scalp irradiation: a single institutional experience. Radiat Oncol J. 2016;34(4):313–21.

    Article  Google Scholar 

  • Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.

    Article  CAS  Google Scholar 

  • Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171–9.

    Article  CAS  Google Scholar 

  • Swanson EL, Amdur RJ, Mendenhall WM, Morris CG, Kirwan JM, Flowers F. Radiotherapy for basal cell carcinoma of the medial canthus region. Laryngoscope. 2009;119(12):2366–8.

    Article  Google Scholar 

  • van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, Steijlen PM, Neumann HA, Nelemans PJ, Kelleners-Smeets NW. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011–20.

    Article  Google Scholar 

  • Work Group, Bichakjian C, Armstrong A, Baum C, Bordeaux JS, Brown M, Busam KJ, Eisen DB, Iyengar V, Lober C, Margolis DJ, Messina J, Miller A, Miller S, Mostow E, Mowad C, Nehal K, Schmitt-Burr K, Sekulic A, Storrs P, Teng J, Yu S, Huang C, Boyer K, Smith Begolka W, Alam M. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540–59.

    Google Scholar 

  • Zagrodnik B, Kempf W, Seifert B, Müller B, Burg G, Urosevic M, Dummer R. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer. 2003;98(12):2708–14.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

    Dirk Vordermark

Authors
  1. Dirk Vordermark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirk Vordermark .

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, University Hospital Mannheim, Mannheim, Germany

    Frederik Wenz

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Vordermark, D. (2019). Radiation Therapy in Basal Cell Carcinoma. In: Wenz, F. (eds) Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-52619-5_14-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52619-5_14-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52619-5

  • Online ISBN: 978-3-319-52619-5

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation